The Veteran's claim for an evaluation higher than 30 percent for pulmonary sarcoidosis prior to April 1, 2016 was denied as the evidence did not show that he required daily high dose corticosteroids or immuno-suppressive medications.,The Veteran's claim for a compensable evaluation for bilateral sarcoidosis of the eye was denied as his vision correction was at least 20/40 in both eyes, without visual field defects.
The deciding factor: The evidence did not show that the Veteran required daily high dose corticosteroids or immuno-suppressive medications to manage his pulmonary sarcoidosis prior to April 1, 2016.,His vision correction was at least 20/40 in both eyes without visual field defects.
- Claimed conditions
- Pulmonary Sarcoidosis, Bilateral Sarcoidosis of the Eye
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- March 17, 2022
- Citation
- 22015439
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 22015439.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Board found the reduction from 100 to 30 percent for pulmonary sarcoidosis was proper, but later determined this decision contained legal errors and revised it to restore the 100 percent rating.
- Whole decision: Remanded (sent back)
The Veteran's claims for extension of the temporary total evaluation and increased evaluations for his service-connected conditions are remanded due to incomplete adjudication and need for additional examinations.
- Whole decision: Granted
The Veteran's pulmonary sarcoidosis with decreased pulmonary function, granuloma, chronic fatigue, headaches, and joint pain is rated at a maximum of 100 percent. The Veteran's depressive disorder and PTSD are each rated at 70 percent. He is also granted TDIU based on his service-connected disabilities.
- Whole decision: Granted
The Veteran's service-connected pulmonary sarcoidosis, requiring continuous outpatient oxygen therapy and making him unable to work, qualifies for a TDIU rating from July 29, 2013.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.